Estimating the Long Term Cost Savings from the Treatment of Alzheimer's Disease: A Modelling Approach
Author: Neumann P.J.
Source: PharmacoEconomics, Volume 17, Number 1, January 2000 , pp. 109-109(1)
Publisher: Adis International
Keywords: Alzheimer's disease, treatment; Anticholinesterases, therapeutic use; Clinical trial design; Cost analysis; Pharmacoeconomics; Rivastigmine, therapeutic use
Language: English
Document Type: Correspondence
Affiliations: 1: Harvard School of Public Health, Boston, Massachusetts, USA
Publication date: 2000-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Neumann P.J.

Shopping cart
Receive new issue alert
Get Permissions